Arrhythmias & EP
Conference Coverage
Thirty-second atrial fib threshold may drive overdiagnosis
BOSTON – The current 30-second threshold for defining clinically meaningful AF “metastasized” from a select subgroup of patients to all AF...
Conference Coverage
Novel targeted cancer drugs cause fewer arrhythmias
Tyrosine kinase inhibitors and other targeted agents have 40% lower cardiac arrhythmia risk than anthracycline-based regimens.
From the Journals
Adding vasopressin in distributive shock may cut AF risk
Adding vasopressin cut risk of atrial fibrillation, compared with catecholamine vasopressors alone.
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
From the Journals
Women’s representation in CV drug trials still lagging
We’ve come a long way in clinical trial representation of women, but there’s more work to do.
Daily News Podcast
MDedge Daily News: Which diabetes drug boosts survival best?
And there’s new promise in early-stage lung cancer.
Latest News
VIDEO: Screening ECG patch boosts AF diagnoses ninefold
ECG patches may provide an inexpensive and noninvasive way to screen for asymptomatic atrial fibrillation in high-risk people.
Conference Coverage
Apixaban prevails in study of 163,000 DOAC users
ORLANDO – Apixaban had lowest rates of both stroke and major bleeding in ARISTOPHANES.
Daily News Podcast
MDedge Daily News: Time to let more pregnant women into drug trials?
And health IT under-users still outnumber super-users.
Conference Coverage
Permanent His-bundle pacing superior to RV pacing
ORLANDO – Large registry highlights reduced morbidity and mortality.
Conference Coverage
Takotsubo cardiomyopathy incidence, mortality on the rise
WASHINGTON – Several risk factors have been identified.